The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
Abstract Introduction Prognostic biomarkers in asthma are needed. The biomarker soluble urokinase plasminogen activator receptor (suPAR) has been associated with asthma control and with prognosis in acutely admitted medical patients. We investigated if suPAR and blood eosinophil counts at the time o...
Main Authors: | K. E. J. Håkansson, Line J. H. Rasmussen, Nina S. Godtfredsen, Oliver D. Tupper, Jesper Eugen-Olsen, Thomas Kallemose, Ove Andersen, Charlotte Suppli Ulrik |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-019-1234-4 |
Similar Items
-
High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
by: Håkansson KEJ, et al.
Published: (2020-04-01) -
Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?
by: Glenn Van Hulst, et al.
Published: (2021-09-01) -
Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
by: Esben Iversen, et al.
Published: (2020-06-01) -
COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
by: Osman Savran, et al.
Published: (2021-02-01) -
Eosinophil granule proteins and bronchial asthma
by: Gerald J Gleich
Published: (1996-01-01)